Dr. Bilal A. Mateen is the inaugural chief AI officer at PATH, an INGO focused on achieving health equity through innovation. He trained as a physician in the United Kingdom and continues to work as an academic in the field of AI4Health, leading a portfolio of more than a quarter of a billion in digital health-focused grants and contracts.

Dr. Bruce Agins is an infectious disease physician and professor at the University of California San Francisco in the Institute for Global Health Sciences, Division of epidemiology, and former medical director of the New York State Department of Health AIDS Institute. Since 2002, he has directed HEALTHQUAL, a capacity-building initiative supporting development of sustainable quality management programs in Ministries of Health. He received his M.D. from Case Western Reserve University and his B.A. in anthropology from Haverford College.

Dr. Burmaa Alexander serves as the head of the influenza surveillance division at The National Center for Communicable Diseases, Ministry of Health, Mongolia. The National Influenza Center has responsibilities for epidemiological, laboratory surveillance, and clinical management for all acute and chronic infectious diseases across Mongolia. Alexander has been at the NCCD since 2002 and started as an epidemiologist. A pediatrician by training, she is a graduate of Irkutsk Medical University.

Dr. Chikwe Ihekweazu is the assistant director general at the World Health Organization for surveillance and health emergency intelligence and leads the WHO Hub for Pandemic and Epidemic Intelligence, based in Berlin, Germany. Previously, Ihekweazu was the first director general of the Nigeria Centre for Disease Control. He acted as interim director of the West Africa Regional Centre for Surveillance and Disease Control through 2017. He trained as an infectious disease epidemiologist and has over 25 years of experience working in senior public health and leadership positions in national public health institutes.

Dr. Chiseche Salome Mibenge is the director for Gender Initiatives at Episcopal Relief & Development, responsible for the design and implementation of the gender strategy and policy for international development programs and humanitarian response. Chiseche is the author of “Sex and International Tribunals: The Erasure of Gender from the War Narrative” (Penn Press.) She is a board member of the Global Interfaith Network for People of all Sexes, Sexual Orientations, and Gender Identities. For two decades, she served as a human rights educator with Utrecht University, Stanford University, and CUNY. Chiseche earned her Ph.D. from Utrecht University in 2010.

Choolwe Jacobs, Ph.D., is co-founder and country lead for Women in Global Health, Zambia chapter. She is a public health specialist and social epidemiologist with over 15 years of extensive engagement in global health.

Dr. Christopher Morgan is senior technical adviser for immunization at Jhpiego. He is a pediatrician, public health physician, and development practitioner with 30 years of experience in immunization; primary health care; and maternal, child, and adolescent health. Morgan participates in advisory groups such as the COVID-19 Vaccines Working Group of the World Health Organization’s Strategic Advisory Group of Experts on Immunization.

Dr. Corine Karema took office as the interim CEO of the RBM Partnership to End Malaria in April 2022. Karema has most recently served as special adviser to the board chair of The Global Fund. Previously, she was the senior malaria program officer at the African Leaders Malaria Alliance and led the malaria experts’ group of the technical panel review of the Global Fund. She served as an independent consultant for many years, where she provided technical assistance to National Malaria Control and Elimination Programs in Africa.

Dr. Dania Albaba is a psychiatry resident at Baylor College of Medicine. She’s a volunteer with the humanitarian NGO MedGlobal.

Dr. David Denning is trained in infectious diseases and has expertise in fungal diseases. He serves as the chief executive of Global Action For Fungal Infections, which advocates for universal access to diagnostics and antifungal medicines. Denning managed the United Kingdom’s National Aspergillosis Centre, Manchester from 2009-2020.